跳转至内容
Merck
CN

SML4137

W6134

≥95% (HPLC)

别名:

N-(2′-Chloro-4′-(2-(4-(ethylsulfonyl)phenyl)acetamido)-[1,1′-biphenyl]-2-yl)acrylamide, N-[2-Chloro-2′-[(1-oxo-2-propen-1-yl)amino][1,1′-biphenyl]-4-yl]-4-(ethylsulfonyl)-benzeneacetamide

登录 查看组织和合同定价。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C25H23ClN2O4S
化学文摘社编号:
分子量:
482.98
NACRES:
NA.21
Assay:
≥95% (HPLC)
Form:
powder
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Segment

assay

≥95% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

SMILES string

C=CC(NC1=CC=CC=C1C2=CC=C(NC(CC3=CC=C(S(=O)(CC)=O)C=C3)=O)C=C2Cl)=O

Biochem/physiol Actions

Cell penetrant, highly potent, selective, and non-toxic RORγ covalent inhibitor.

W6134 is a highly potent, selective RORγ (retinoic acid receptor-related orphan receptor γ) armed with a cell-permeable acrylamide warhead, which specifically targets RORγ (IC50 = 210 nM in HEK293Tcells co-transfected with Gal4-RORγ-LBD) by covalently modifying RORγ-Cys320 thiol while showing minimal activity against other nuclear receptors such as RORα, RXRγ, and ERRγ (IC50 > 20 μM). W6134 is effective in inducing apoptosis in C4-2B and 22Rv1 cell lines and reduces RORγ-mediated transcription, leading to decreased androgen receptor (AR) expression in a dose- and time-dependent manner. When tested in vivo (T1/2 = 21.3 min in mouse liver microsomes), W6134 significantly suppresses tumor growth in castration-resistant prostate cancers (CRPC) xenograft mouse models (5 or 10 mg/kg, i.p.) demonstrating its efficacy and safety.


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库